Drug firm Dr Reddy's Laboratories has received the approval from USFDA for its drug Zanatane capsules and has launched the drug in the US market.
The capsules available in the strengths of 10 mg, 20 mg and 40 mg and in boxes of 30 are used to treat severe form of acne namely, severe recalcitrant nodular acne.
AdvertisementThe capsules are generic version of Accutane (Isotretinoin Capsules USP) of Hoffman- La Roche Inc.
This launch has hiked the value of the company's shares.
P New Model Has Been Designed to Predict Final Menstrual Period Mothers Face Hundreds of Questions Every Day by Their Little Ones M
You May Also Like